172 related articles for article (PubMed ID: 30073607)
1. Plasma profiling of amino acids distinguishes acute gout from asymptomatic hyperuricemia.
Luo Y; Wang L; Liu XY; Chen X; Song YX; Li XH; Jiang C; Peng A; Liu JY
Amino Acids; 2018 Nov; 50(11):1539-1548. PubMed ID: 30073607
[TBL] [Abstract][Full Text] [Related]
2. Metabolomic analysis for asymptomatic hyperuricemia and gout based on a combination of dried blood spot sampling and mass spectrometry technology.
Liu S; Liu Y; Wu X; Liu Z
J Orthop Surg Res; 2023 Oct; 18(1):769. PubMed ID: 37821971
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics approach by
Zhang Y; Zhang H; Chang D; Guo F; Pan H; Yang Y
Arthritis Res Ther; 2018 Jun; 20(1):111. PubMed ID: 29871692
[TBL] [Abstract][Full Text] [Related]
4. Levels of Cytokines and MicroRNAs in Individuals With Asymptomatic Hyperuricemia and Ultrasonographic Findings of Gout: A Bench-to-Bedside Approach.
Estevez-Garcia IO; Gallegos-Nava S; Vera-Pérez E; Silveira LH; Ventura-Ríos L; Vancini G; Hernández-Díaz C; Sánchez-Muñoz F; Ballinas-Verdugo MA; Gutierrez M; Pineda C; Rodriguez-Henriquez P; Castillo-Martínez D; Amezcua-Guerra LM
Arthritis Care Res (Hoboken); 2018 Dec; 70(12):1814-1821. PubMed ID: 29457379
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic Profiling of Amino Acids in Human Plasma Distinguishes Diabetic Kidney Disease From Type 2 Diabetes Mellitus.
Zhou C; Zhang Q; Lu L; Wang J; Liu D; Liu Z
Front Med (Lausanne); 2021; 8():765873. PubMed ID: 34912824
[No Abstract] [Full Text] [Related]
6. The natural history of hyperuricemia among asymptomatic relatives of patients with gout.
Yü T; Kaung C
Adv Exp Med Biol; 1980; 122A():1-7. PubMed ID: 7424621
[TBL] [Abstract][Full Text] [Related]
7. Effect of a traditional Chinese medicine prescription Quzhuotongbi decoction on hyperuricemia model rats studied by using serum metabolomics based on gas chromatography-mass spectrometry.
Chen J; Zhou J; Wei S; Xie Z; Wen C; Xu G
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jul; 1026():272-278. PubMed ID: 26632444
[TBL] [Abstract][Full Text] [Related]
8. Is it time to revise the normal range of serum uric acid levels?
Desideri G; Castaldo G; Lombardi A; Mussap M; Testa A; Pontremoli R; Punzi L; Borghi C
Eur Rev Med Pharmacol Sci; 2014; 18(9):1295-306. PubMed ID: 24867507
[TBL] [Abstract][Full Text] [Related]
9. Ultrasonographic assessment of joint pathology in type 2 diabetes and hyperuricemia: The Fremantle Diabetes Study Phase II.
Keen HI; Davis WA; Latkovic E; Drinkwater JJ; Nossent J; Davis TME
J Diabetes Complications; 2018 Apr; 32(4):400-405. PubMed ID: 29483015
[TBL] [Abstract][Full Text] [Related]
10. Ultrasound Features of the First Metatarsophalangeal Joint in Gout and Asymptomatic Hyperuricemia: Comparison With Normouricemic Individuals.
Stewart S; Dalbeth N; Vandal AC; Allen B; Miranda R; Rome K
Arthritis Care Res (Hoboken); 2017 Jun; 69(6):875-883. PubMed ID: 27635596
[TBL] [Abstract][Full Text] [Related]
11. Differences in MSU-induced superoxide responses by neutrophils from gout subjects compared to healthy controls and a role for environmental inflammatory cytokines and hyperuricemia in neutrophil function and survival.
Martin WJ; Grainger R; Harrison A; Harper JL
J Rheumatol; 2010 Jun; 37(6):1228-35. PubMed ID: 20395644
[TBL] [Abstract][Full Text] [Related]
12. Management of gout and hyperuricemia: Multidisciplinary consensus in Taiwan.
Yu KH; Chen DY; Chen JH; Chen SY; Chen SM; Cheng TT; Hsieh SC; Hsieh TY; Hsu PF; Kuo CF; Kuo MC; Lam HC; Lee IT; Liang TH; Lin HY; Lin SC; Tsai WP; Tsay GJ; Wei JC; Yang CH; Tsai WC
Int J Rheum Dis; 2018 Apr; 21(4):772-787. PubMed ID: 29363262
[TBL] [Abstract][Full Text] [Related]
13. GLUT9 influences uric acid concentration in patients with Lesch-Nyhan disease.
Torres RJ; Puig JG
Int J Rheum Dis; 2018 Jun; 21(6):1270-1276. PubMed ID: 29879316
[TBL] [Abstract][Full Text] [Related]
14. Serum Metabolomics Identifies Dysregulated Pathways and Potential Metabolic Biomarkers for Hyperuricemia and Gout.
Shen X; Wang C; Liang N; Liu Z; Li X; Zhu ZJ; Merriman TR; Dalbeth N; Terkeltaub R; Li C; Yin H
Arthritis Rheumatol; 2021 Sep; 73(9):1738-1748. PubMed ID: 33760368
[TBL] [Abstract][Full Text] [Related]
15. [Hyperlipoproteinemia in primary gout and asymptomatic hyperuricemia].
Kullich W; Ulreich A; Klein G
Wien Med Wochenschr; 1988 May; 138(10):221-5. PubMed ID: 3407202
[TBL] [Abstract][Full Text] [Related]
16. [Hyperuricemia and disorders in content of amino acids-purine precursors in patients with autoimmune diseases and gout].
Nikolenko IuI; Siniachenko OV; Anan'eva MN; Nikolenko VIu; Dubiaga VV; Shchukin IN
Lik Sprava; 2005 Jun; (4):34-6. PubMed ID: 16158711
[TBL] [Abstract][Full Text] [Related]
17. Review of the ophthalmic manifestations of gout and uric acid crystal deposition.
Ao J; Goldblatt F; Casson RJ
Clin Exp Ophthalmol; 2017 Jan; 45(1):73-80. PubMed ID: 27010973
[TBL] [Abstract][Full Text] [Related]
18. Myeloperoxidase and oxidation of uric acid in gout: implications for the clinical consequences of hyperuricaemia.
Stamp LK; Turner R; Khalilova IS; Zhang M; Drake J; Forbes LV; Kettle AJ
Rheumatology (Oxford); 2014 Nov; 53(11):1958-65. PubMed ID: 24899662
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of hyperuricemia in a population of the coastal city of Qingdao, China.
Nan H; Qiao Q; Dong Y; Gao W; Tang B; Qian R; Tuomilehto J
J Rheumatol; 2006 Jul; 33(7):1346-50. PubMed ID: 16821269
[TBL] [Abstract][Full Text] [Related]
20. The interplay between diet, urate transporters and the risk for gout and hyperuricemia: current and future directions.
Torralba KD; De Jesus E; Rachabattula S
Int J Rheum Dis; 2012 Dec; 15(6):499-506. PubMed ID: 23253231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
